{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:33:43Z","timestamp":1780677223252,"version":"3.54.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071383"],"award-info":[{"award-number":["82071383"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-08527-5","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T19:58:25Z","timestamp":1753819105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pantothenic acid ameliorates hepatic fibrosis by targeting IGFBP6 to regulate the TGF-\u03b2\/SMADs pathway"],"prefix":"10.1038","volume":"8","author":[{"given":"Zhengxin","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengsen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongcheng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianning","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuepeng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7592-9485","authenticated-orcid":false,"given":"Bin","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"8527_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","volume":"6","author":"V Hernandez-Gea","year":"2011","unstructured":"Hernandez-Gea, V. & Friedman, S. L. Pathogenesis of liver fibrosis. Annu Rev. Pathol. 6, 425\u2013456 (2011).","journal-title":"Annu Rev. Pathol."},{"key":"8527_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva, T. & Brenner, D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat. Rev. Gastroenterol. Hepatol. 18, 151\u2013166 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"8527_CR3","doi-asserted-by":"crossref","unstructured":"Banerjee, A. & Farci, P. Fibrosis and hepatocarcinogenesis: role of gene-environment interactions in liver disease progression. Int. J. Mol. Sci. 25, 8641 (2024).","DOI":"10.3390\/ijms25168641"},{"key":"8527_CR4","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","volume":"62","author":"C Trautwein","year":"2015","unstructured":"Trautwein, C., Friedman, S. L., Schuppan, D. & Pinzani, M. Hepatic fibrosis: concept to treatment. J. Hepatol. 62, S15\u2013S24 (2015).","journal-title":"J. Hepatol."},{"key":"8527_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154721","volume":"113","author":"Y Zheng","year":"2023","unstructured":"Zheng, Y., Xie, L., Yang, D., Luo, K. & Li, X. Small-molecule natural plants for reversing liver fibrosis based on modulation of hepatic stellate cells activation: an update. Phytomedicine 113, 154721 (2023).","journal-title":"Phytomedicine"},{"key":"8527_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jhep.2020.02.027","volume":"73","author":"SA Harrison","year":"2020","unstructured":"Harrison, S. A. et al. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials. J. Hepatol. 73, 26\u201339 (2020).","journal-title":"J. Hepatol."},{"key":"8527_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cgh.2023.04.003","volume":"22","author":"QM Anstee","year":"2024","unstructured":"Anstee, Q. M. et al. Cenicriviroc lacked efficacy to treat liver fibrosis in nonalcoholic steatohepatitis: AURORA phase III randomized study. Clin. Gastroenterol. Hepatol. 22, 124\u2013134.e121 (2024).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"8527_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida, T. & Friedman, S. L. Mechanisms of hepatic stellate cell activation. Nat. Rev. Gastroenterol. Hepatol. 14, 397\u2013411 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"8527_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jare.2022.08.006","volume":"47","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z. et al. ANGPTL8 accelerates liver fibrosis mediated by HFD-induced inflammatory activity via LILRB2\/ERK signaling pathways. J. Adv. Res. 47, 41\u201356 (2023).","journal-title":"J. Adv. Res."},{"key":"8527_CR10","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jhep.2023.05.043","volume":"79","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. GARP on hepatic stellate cells is essential for the development of liver fibrosis. J. Hepatol. 79, 1214\u20131225 (2023).","journal-title":"J. Hepatol."},{"key":"8527_CR11","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1021\/acsnano.3c06107","volume":"18","author":"J Shinn","year":"2024","unstructured":"Shinn, J. et al. Antioxidative hyaluronic acid-bilirubin nanomedicine targeting activated hepatic stellate cells for anti-hepatic-fibrosis therapy. ACS Nano 18, 4704\u20134716 (2024).","journal-title":"ACS Nano"},{"key":"8527_CR12","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1016\/j.ymthe.2023.08.017","volume":"31","author":"M Hao","year":"2023","unstructured":"Hao, M. et al. Atractylodinol prevents pulmonary fibrosis through inhibiting TGF-beta receptor 1 recycling by stabilizing vimentin. Mol. Ther. 31, 3015\u20133033 (2023).","journal-title":"Mol. Ther."},{"key":"8527_CR13","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1681\/ASN.2015040356","volume":"27","author":"DA Yuen","year":"2016","unstructured":"Yuen, D. A. et al. Recombinant N-terminal Slit2 inhibits TGF-beta-induced fibroblast activation and renal fibrosis. J. Am. Soc. Nephrol. 27, 2609\u20132615 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"8527_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46711-z","volume":"15","author":"Y Katanasaka","year":"2024","unstructured":"Katanasaka, Y. et al. Fibroblast-specific PRMT5 deficiency suppresses cardiac fibrosis and left ventricular dysfunction in male mice. Nat. Commun. 15, 2472 (2024).","journal-title":"Nat. Commun."},{"key":"8527_CR15","doi-asserted-by":"crossref","unstructured":"Akhurst, R. J. Targeting TGF-beta Signaling for Therapeutic Gain. Cold Spring Harb. Perspect. Biol. 9, a022301 (2017).","DOI":"10.1101\/cshperspect.a022301"},{"key":"8527_CR16","doi-asserted-by":"publisher","first-page":"964","DOI":"10.7150\/ijbs.4564","volume":"8","author":"EC Connolly","year":"2012","unstructured":"Connolly, E. C., Freimuth, J. & Akhurst, R. J. Complexities of TGF-beta targeted cancer therapy. Int. J. Biol. Sci. 8, 964\u2013978 (2012).","journal-title":"Int. J. Biol. Sci."},{"key":"8527_CR17","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/nrd1580","volume":"3","author":"JM Yingling","year":"2004","unstructured":"Yingling, J. M., Blanchard, K. L. & Sawyer, J. S. Development of TGF-beta signalling inhibitors for cancer therapy. Nat. Rev. Drug Discov. 3, 1011\u20131022 (2004).","journal-title":"Nat. Rev. Drug Discov."},{"key":"8527_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.redox.2014.01.012","volume":"2","author":"F Jiang","year":"2014","unstructured":"Jiang, F., Liu, G. S., Dusting, G. J. & Chan, E. C. NADPH oxidase-dependent redox signaling in TGF-beta-mediated fibrotic responses. Redox Biol. 2, 267\u2013272 (2014).","journal-title":"Redox Biol."},{"key":"8527_CR19","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1210\/endrev\/bnad008","volume":"44","author":"RC Baxter","year":"2023","unstructured":"Baxter, R. C. Signaling pathways of the insulin-like growth factor binding proteins. Endocr. Rev. 44, 753\u2013778 (2023).","journal-title":"Endocr. Rev."},{"key":"8527_CR20","first-page":"761","volume":"20","author":"V Hwa","year":"1999","unstructured":"Hwa, V., Oh, Y. & Rosenfeld, R. G. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr. Rev. 20, 761\u2013787 (1999).","journal-title":"Endocr. Rev."},{"key":"8527_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jhep.2020.02.005","volume":"73","author":"JP Arab","year":"2020","unstructured":"Arab, J. P. et al. Hepatic stellate cell activation promotes alcohol-induced steatohepatitis through Igfbp3 and SerpinA12. J. Hepatol. 73, 149\u2013160 (2020).","journal-title":"J. Hepatol."},{"key":"8527_CR22","doi-asserted-by":"publisher","first-page":"8832","DOI":"10.1093\/nar\/gky589","volume":"46","author":"YY Lee","year":"2018","unstructured":"Lee, Y. Y. et al. Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis. Nucleic Acids Res. 46, 8832\u20138847 (2018).","journal-title":"Nucleic Acids Res."},{"key":"8527_CR23","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/S0008-6363(96)00236-2","volume":"33","author":"A Kluge","year":"1997","unstructured":"Kluge, A. et al. Coordinate expression of the insulin-like growth factor system after microembolisation in porcine heart. Cardiovasc. Res. 33, 324\u2013331 (1997).","journal-title":"Cardiovasc. Res."},{"key":"8527_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1042\/CS20120343","volume":"124","author":"LA Bach","year":"2013","unstructured":"Bach, L. A., Fu, P. & Yang, Z. Insulin-like growth factor-binding protein-6 and cancer. Clin. Sci.124, 215\u2013229 (2013).","journal-title":"Clin. Sci."},{"key":"8527_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1574-6976.2007.00093.x","volume":"32","author":"C Spry","year":"2008","unstructured":"Spry, C., Kirk, K. & Saliba, K. J. Coenzyme A biosynthesis: an antimicrobial drug target. FEMS Microbiol. Rev. 32, 56\u2013106 (2008).","journal-title":"FEMS Microbiol. Rev."},{"key":"8527_CR26","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.ijbiomac.2022.06.014","volume":"213","author":"MZ Nawaz","year":"2022","unstructured":"Nawaz, M. Z. et al. Discovery and characterization of dual inhibitors of human Vanin-1 and Vanin-2 enzymes through molecular docking and dynamic simulation-based approach. Int J. Biol. Macromol. 213, 1088\u20131097 (2022).","journal-title":"Int J. Biol. Macromol."},{"key":"8527_CR27","doi-asserted-by":"crossref","unstructured":"Frost, Z., Bakhit, S., Amaefuna, C. N., Powers, R. V. & Ramana, K. V. Recent advances on the role of B vitamins in cancer prevention and progression. Int. J. Mol. Sci. 26, 1967 (2025).","DOI":"10.3390\/ijms26051967"},{"key":"8527_CR28","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1038\/s42255-023-00915-7","volume":"5","author":"P Kreuzaler","year":"2023","unstructured":"Kreuzaler, P. et al. Vitamin B(5) supports MYC oncogenic metabolism and tumor progression in breast cancer. Nat. Metab. 5, 1870\u20131886 (2023).","journal-title":"Nat. Metab."},{"key":"8527_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn5135","volume":"15","author":"SA Mian","year":"2023","unstructured":"Mian, S. A. et al. Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1-mutated myelodysplasia. Sci. Transl. Med. 15, eabn5135 (2023).","journal-title":"Sci. Transl. Med."},{"key":"8527_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.addr.2021.04.008","volume":"174","author":"CY Lin","year":"2021","unstructured":"Lin, C. Y., Adhikary, P. & Cheng, K. Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis. Adv. Drug Deliv. Rev. 174, 127\u2013139 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"8527_CR31","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng, X. M., Nikolic-Paterson, D. J. & Lan, H. Y. TGF-beta: the master regulator of fibrosis. Nat. Rev. Nephrol. 12, 325\u2013338 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"8527_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2597-7","volume":"11","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Ginsenoside Rg3 promotes regression from hepatic fibrosis through reducing inflammation-mediated autophagy signaling pathway. Cell Death Dis. 11, 454 (2020).","journal-title":"Cell Death Dis."},{"key":"8527_CR33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","volume":"68-69","author":"D Schuppan","year":"2018","unstructured":"Schuppan, D., Ashfaq-Khan, M., Yang, A. T. & Kim, Y. O. Liver fibrosis: Direct antifibrotic agents and targeted therapies. Matrix Biol. 68-69, 435\u2013451 (2018).","journal-title":"Matrix Biol."},{"key":"8527_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2023.0125","volume":"30","author":"K Sankar","year":"2024","unstructured":"Sankar, K. et al. Recent advances in the management of hepatocellular carcinoma. Clin. Mol. Hepatol. 30, 1\u201315 (2024).","journal-title":"Clin. Mol. Hepatol."},{"key":"8527_CR35","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S0168-8278(03)00005-9","volume":"38","author":"VJ Desmet","year":"2003","unstructured":"Desmet, V. J. et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. J. Hepatol. 38, 382\u2013386 (2003).","journal-title":"J. Hepatol."},{"key":"8527_CR36","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.3748\/wjg.v25.i34.5069","volume":"25","author":"N Huda","year":"2019","unstructured":"Huda, N. et al. Hepatic senescence, the good and the bad. World J. Gastroenterol. 25, 5069\u20135081 (2019).","journal-title":"World J. Gastroenterol."},{"key":"8527_CR37","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1194\/jlr.M800496-JLR200","volume":"50","author":"H Ikeda","year":"2009","unstructured":"Ikeda, H. et al. Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2. J. Lipid Res. 50, 556\u2013564 (2009).","journal-title":"J. Lipid Res."},{"key":"8527_CR38","doi-asserted-by":"crossref","unstructured":"Liso, A. et al. IGFBP-6: At the crossroads of immunity, tissue repair and fibrosis. Int. J. Mol. Sci. 23, 4358 (2022).","DOI":"10.3390\/ijms23084358"},{"key":"8527_CR39","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.5551\/jat.52993","volume":"27","author":"Y Liu","year":"2020","unstructured":"Liu, Y., Huan, W., Wu, J., Zou, S. & Qu, L. IGFBP6 is downregulated in unstable carotid atherosclerotic plaques according to an integrated bioinformatics analysis and experimental verification. J. Atheroscler. Thromb. 27, 1068\u20131085 (2020).","journal-title":"J. Atheroscler. Thromb."},{"key":"8527_CR40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.33549\/physiolres.930538","volume":"54","author":"Z Jarkovska","year":"2005","unstructured":"Jarkovska, Z. et al. Plasma ghrelin levels in patients with end-stage renal disease. Physiol. Res. 54, 403\u2013408 (2005).","journal-title":"Physiol. Res."},{"key":"8527_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/prca.201700067","volume":"12","author":"A Christensson","year":"2018","unstructured":"Christensson, A. et al. The impact of the glomerular filtration rate on the human plasma proteome. Proteom. Clin. Appl 12, e1700067 (2018).","journal-title":"Proteom. Clin. Appl"},{"key":"8527_CR42","doi-asserted-by":"publisher","first-page":"e520","DOI":"10.1210\/clinem\/dgaa792","volume":"106","author":"TL Stanley","year":"2021","unstructured":"Stanley, T. L. et al. Relationship of IGF-1 and IGF-binding proteins to disease severity and glycemia in nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metab. 106, e520\u2013e533 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"8527_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11010-020-03728-4","volume":"469","author":"M Martinez-Castillo","year":"2020","unstructured":"Martinez-Castillo, M. et al. Differential production of insulin-like growth factor-binding proteins in liver fibrosis progression. Mol. Cell Biochem. 469, 65\u201375 (2020).","journal-title":"Mol. Cell Biochem."},{"key":"8527_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1152\/physiolgenomics.2000.2.3.143","volume":"2","author":"JA Warrington","year":"2000","unstructured":"Warrington, J. A., Nair, A., Mahadevappa, M. & Tsyganskaya, M. Comparison of human adult and fetal expression and identification of 535 housekeeping\/maintenance genes. Physiol. Genomics 2, 143\u2013147 (2000).","journal-title":"Physiol. Genomics"},{"key":"8527_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155465","volume":"128","author":"S Xu","year":"2024","unstructured":"Xu, S. et al. Esculin inhibits hepatic stellate cell activation and CCl(4)-induced liver fibrosis by activating the Nrf2\/GPX4 signaling pathway. Phytomedicine 128, 155465 (2024).","journal-title":"Phytomedicine"},{"key":"8527_CR46","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","volume":"15","author":"JHW Distler","year":"2019","unstructured":"Distler, J. H. W. et al. Shared and distinct mechanisms of fibrosis. Nat. Rev. Rheumatol. 15, 705\u2013730 (2019).","journal-title":"Nat. Rev. Rheumatol."},{"key":"8527_CR47","doi-asserted-by":"crossref","unstructured":"Semenovich, D. S., Plotnikov, E. Y., Titko, O. V., Lukiyenko, E. P. & Kanunnikova, N. P. Effects of panthenol and N-acetylcysteine on changes in the redox state of brain mitochondria under oxidative stress in vitro. Antioxidants 10, 1699 (2021).","DOI":"10.3390\/antiox10111699"},{"key":"8527_CR48","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cbi.2006.04.014","volume":"163","author":"F Depeint","year":"2006","unstructured":"Depeint, F., Bruce, W. R., Shangari, N., Mehta, R. & O\u2019Brien, P. J. Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism. Chem. Biol. Interact. 163, 94\u2013112 (2006).","journal-title":"Chem. Biol. Interact."},{"key":"8527_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111741","volume":"41","author":"C Chen","year":"2022","unstructured":"Chen, C. et al. Vitamin B5 rewires Th17 cell metabolism via impeding PKM2 nuclear translocation. Cell Rep. 41, 111741 (2022).","journal-title":"Cell Rep."},{"key":"8527_CR50","doi-asserted-by":"publisher","first-page":"eado0020","DOI":"10.1126\/scitranslmed.ado0020","volume":"17","author":"S Sun","year":"2025","unstructured":"Sun, S. et al. Targeting GOLPH3L improves glioblastoma radiotherapy by regulating STING-NLRP3-mediated tumor immune microenvironment reprogramming. Sci. Transl. Med. 17, eado0020 (2025).","journal-title":"Sci. Transl. Med."},{"key":"8527_CR51","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/978-1-4939-6786-5_19","volume":"1559","author":"YO Kim","year":"2017","unstructured":"Kim, Y. O., Popov, Y. & Schuppan, D. Optimized mouse models for liver fibrosis. Methods Mol. Biol. 1559, 279\u2013296 (2017).","journal-title":"Methods Mol. Biol."},{"key":"8527_CR52","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jhep.2010.04.025","volume":"53","author":"J Trebicka","year":"2010","unstructured":"Trebicka, J. et al. Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells. J. Hepatol. 53, 702\u2013712 (2010).","journal-title":"J. Hepatol."},{"key":"8527_CR53","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nprot.2015.017","volume":"10","author":"I Mederacke","year":"2015","unstructured":"Mederacke, I., Dapito, D. H., Affo, S., Uchinami, H. & Schwabe, R. F. High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers. Nat. Protoc. 10, 305\u2013315 (2015).","journal-title":"Nat. Protoc."},{"key":"8527_CR54","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/978-1-0716-2010-6_27","volume":"2434","author":"K Elvevold","year":"2022","unstructured":"Elvevold, K., Kyrrestad, I. & Smedsrod, B. Protocol for Isolation and Culture of Mouse Hepatocytes (HCs), Kupffer Cells (KCs), and Liver Sinusoidal Endothelial Cells (LSECs) in analyses of hepatic drug distribution. Methods Mol. Biol. 2434, 385\u2013402 (2022).","journal-title":"Methods Mol. Biol."},{"key":"8527_CR55","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","volume":"154","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154, 1380\u20131389 (2013).","journal-title":"Cell"},{"key":"8527_CR56","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ejmech.2016.07.024","volume":"123","author":"RR Ruddarraju","year":"2016","unstructured":"Ruddarraju, R. R. et al. Design, synthesis, anticancer, antimicrobial activities and molecular docking studies of theophylline containing acetylenes and theophylline containing 1,2,3-triazoles with variant nucleoside derivatives. Eur. J. Med. Chem. 123, 379\u2013396 (2016).","journal-title":"Eur. J. Med. Chem."},{"key":"8527_CR57","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00249-021-01534-4","volume":"50","author":"A Sedivy","year":"2021","unstructured":"Sedivy, A. Standard operating procedure for NanoTemper Monolith measurements. Eur. Biophys. J. 50, 381\u2013387 (2021).","journal-title":"Eur. Biophys. J."},{"key":"8527_CR58","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/nprot.2014.138","volume":"9","author":"R Jafari","year":"2014","unstructured":"Jafari, R. et al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat. Protoc. 9, 2100\u20132122 (2014).","journal-title":"Nat. Protoc."},{"key":"8527_CR59","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1053\/j.gastro.2021.12.250","volume":"162","author":"T Qian","year":"2022","unstructured":"Qian, T. et al. Molecular signature predictive of long-term liver fibrosis progression to inform antifibrotic drug development. Gastroenterology 162, 1210\u20131225 (2022).","journal-title":"Gastroenterology"},{"key":"8527_CR60","doi-asserted-by":"crossref","unstructured":"Son, J. A. et al. Novel gene signatures as prognostic biomarkers for predicting the recurrence of hepatocellular carcinoma. Cancers 14, 865 (2022).","DOI":"10.3390\/cancers14040865"},{"key":"8527_CR61","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/hep.29606","volume":"67","author":"Q Shen","year":"2018","unstructured":"Shen, Q. et al. Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma. Hepatology 67, 1360\u20131377 (2018).","journal-title":"Hepatology"},{"key":"8527_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72172-7","volume":"10","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension. Sci. Rep. 10, 15558 (2020).","journal-title":"Sci. Rep."},{"key":"8527_CR63","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/hep.26429","volume":"58","author":"JP Pradere","year":"2013","unstructured":"Pradere, J. P. et al. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology 58, 1461\u20131473 (2013).","journal-title":"Hepatology"},{"key":"8527_CR64","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13069-015-0031-z","volume":"8","author":"A El Taghdouini","year":"2015","unstructured":"El Taghdouini, A., Najimi, M., Sancho-Bru, P., Sokal, E. & van Grunsven, L. A. In vitro reversion of activated primary human hepatic stellate cells. Fibrogenes. Tissue Repair 8, 14 (2015).","journal-title":"Fibrogenes. Tissue Repair"},{"key":"8527_CR65","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","volume":"575","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran, P. et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 575, 512\u2013518 (2019).","journal-title":"Nature"},{"key":"8527_CR66","unstructured":"Regev, A. et al. The human cell atlas. Elife 6, 27041 (2017)."},{"key":"8527_CR67","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00018-023-05032-y","volume":"80","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Disruption of cholangiocyte-B cell crosstalk by blocking the CXCL12-CXCR4 axis alleviates liver fibrosis. Cell Mol. Life Sci. 80, 379 (2023).","journal-title":"Cell Mol. Life Sci."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08527-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08527-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08527-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T09:03:16Z","timestamp":1757322196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08527-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8527"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08527-5","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1127"}}